Brian Jason Wainger, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 16 | 2024 | 1414 | 3.500 |
Why?
|
| Motor Neurons | 16 | 2024 | 844 | 2.940 |
Why?
|
| Induced Pluripotent Stem Cells | 13 | 2024 | 1736 | 1.940 |
Why?
|
| Nociceptors | 4 | 2023 | 432 | 1.310 |
Why?
|
| Sensory Receptor Cells | 3 | 2023 | 493 | 1.070 |
Why?
|
| Pick Disease of the Brain | 1 | 2024 | 43 | 0.920 |
Why?
|
| Silymarin | 1 | 2023 | 40 | 0.890 |
Why?
|
| Phenylenediamines | 2 | 2021 | 90 | 0.770 |
Why?
|
| Models, Neurological | 4 | 2019 | 1775 | 0.760 |
Why?
|
| Frontotemporal Dementia | 1 | 2024 | 248 | 0.760 |
Why?
|
| Carbamates | 2 | 2021 | 196 | 0.710 |
Why?
|
| Neuromuscular Junction | 1 | 2021 | 397 | 0.670 |
Why?
|
| Pain | 5 | 2023 | 4988 | 0.620 |
Why?
|
| Spinal Cord | 4 | 2021 | 1810 | 0.600 |
Why?
|
| Action Potentials | 5 | 2019 | 1806 | 0.530 |
Why?
|
| Organoids | 1 | 2021 | 701 | 0.520 |
Why?
|
| Spinal Nerves | 2 | 2014 | 86 | 0.490 |
Why?
|
| Cerebral Cortex | 3 | 2023 | 5709 | 0.480 |
Why?
|
| Pluripotent Stem Cells | 2 | 2019 | 795 | 0.480 |
Why?
|
| Evoked Potentials, Motor | 2 | 2020 | 454 | 0.470 |
Why?
|
| Post-Traumatic Headache | 1 | 2014 | 74 | 0.420 |
Why?
|
| Trigeminal Nerve | 1 | 2014 | 249 | 0.420 |
Why?
|
| Neural Inhibition | 1 | 2015 | 602 | 0.400 |
Why?
|
| Ganglia, Spinal | 3 | 2023 | 519 | 0.390 |
Why?
|
| Cervical Vertebrae | 2 | 2014 | 976 | 0.360 |
Why?
|
| Fibroblasts | 5 | 2014 | 4162 | 0.350 |
Why?
|
| Autonomic Nervous System | 1 | 2014 | 672 | 0.330 |
Why?
|
| Axons | 6 | 2023 | 1685 | 0.300 |
Why?
|
| Methylprednisolone | 1 | 2009 | 387 | 0.300 |
Why?
|
| Neuralgia | 2 | 2023 | 570 | 0.290 |
Why?
|
| Superoxide Dismutase | 4 | 2015 | 596 | 0.250 |
Why?
|
| Receptor, PAR-1 | 1 | 2023 | 113 | 0.220 |
Why?
|
| Poly A | 1 | 2022 | 185 | 0.220 |
Why?
|
| Ion Channels | 3 | 2019 | 1056 | 0.210 |
Why?
|
| Neuroma | 1 | 2023 | 103 | 0.210 |
Why?
|
| Phantom Limb | 1 | 2023 | 91 | 0.210 |
Why?
|
| Mice | 19 | 2024 | 81201 | 0.200 |
Why?
|
| Genes, Regulator | 1 | 2022 | 378 | 0.200 |
Why?
|
| Calcium Channels, N-Type | 1 | 2021 | 39 | 0.200 |
Why?
|
| Mexiletine | 1 | 2020 | 31 | 0.190 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2021 | 61 | 0.190 |
Why?
|
| Staphylococcus aureus | 2 | 2023 | 1453 | 0.190 |
Why?
|
| Peptide Hydrolases | 1 | 2023 | 634 | 0.190 |
Why?
|
| Muscle Cells | 1 | 2021 | 197 | 0.190 |
Why?
|
| Pruritus | 1 | 2023 | 361 | 0.180 |
Why?
|
| Proteins | 1 | 2015 | 6100 | 0.180 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2019 | 58 | 0.180 |
Why?
|
| Calcium | 3 | 2023 | 5755 | 0.180 |
Why?
|
| Animals | 22 | 2024 | 168768 | 0.170 |
Why?
|
| Hyperalgesia | 2 | 2021 | 502 | 0.170 |
Why?
|
| Presynaptic Terminals | 1 | 2021 | 302 | 0.170 |
Why?
|
| Neurofibromatosis 2 | 1 | 2021 | 380 | 0.150 |
Why?
|
| Nerve Block | 2 | 2014 | 644 | 0.150 |
Why?
|
| Cyclic AMP | 1 | 2001 | 1472 | 0.150 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2019 | 449 | 0.140 |
Why?
|
| Humans | 34 | 2024 | 744366 | 0.140 |
Why?
|
| Staphylococcal Infections | 2 | 2023 | 1400 | 0.140 |
Why?
|
| Muscle Proteins | 1 | 2001 | 1158 | 0.130 |
Why?
|
| Neurons | 4 | 2023 | 9340 | 0.130 |
Why?
|
| Neurilemmoma | 1 | 2021 | 547 | 0.130 |
Why?
|
| Cell Culture Techniques | 2 | 2014 | 1678 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 944 | 0.130 |
Why?
|
| Patch-Clamp Techniques | 2 | 2014 | 964 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 2 | 2014 | 430 | 0.120 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2018 | 372 | 0.120 |
Why?
|
| Spinal Cord Injuries | 1 | 2022 | 931 | 0.120 |
Why?
|
| Dysautonomia, Familial | 1 | 2014 | 95 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 9647 | 0.120 |
Why?
|
| Astrocytes | 1 | 2021 | 1273 | 0.120 |
Why?
|
| Dystonic Disorders | 1 | 2018 | 329 | 0.120 |
Why?
|
| RNA, Transfer, Tyr | 1 | 2013 | 4 | 0.120 |
Why?
|
| Skin | 2 | 2021 | 4372 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.110 |
Why?
|
| Sodium Channel Blockers | 1 | 2014 | 176 | 0.110 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 315 | 0.110 |
Why?
|
| Neurogenesis | 1 | 2019 | 838 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2004 | 4463 | 0.100 |
Why?
|
| Electrical Synapses | 1 | 2011 | 19 | 0.100 |
Why?
|
| Injections, Intra-Articular | 2 | 2010 | 278 | 0.100 |
Why?
|
| Neural Stem Cells | 2 | 2018 | 851 | 0.100 |
Why?
|
| Anticonvulsants | 1 | 2021 | 1916 | 0.100 |
Why?
|
| Lidocaine | 1 | 2014 | 544 | 0.090 |
Why?
|
| Gene Expression | 1 | 2023 | 7798 | 0.090 |
Why?
|
| Bupivacaine | 1 | 2014 | 411 | 0.090 |
Why?
|
| Consensus | 1 | 2019 | 2960 | 0.090 |
Why?
|
| Double-Blind Method | 2 | 2021 | 12025 | 0.090 |
Why?
|
| Mice, Knockout | 5 | 2023 | 14561 | 0.090 |
Why?
|
| Phenotype | 2 | 2019 | 16367 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2014 | 12207 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 685 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 1622 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 10943 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2009 | 192 | 0.080 |
Why?
|
| Stem Cells | 1 | 2021 | 3567 | 0.080 |
Why?
|
| Cell Differentiation | 5 | 2022 | 11486 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2014 | 9735 | 0.070 |
Why?
|
| Mutation | 5 | 2021 | 29786 | 0.070 |
Why?
|
| Anesthetics, Local | 1 | 2014 | 985 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2014 | 19233 | 0.070 |
Why?
|
| Membrane Proteins | 2 | 2019 | 7882 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4925 | 0.070 |
Why?
|
| Nervous System | 1 | 2009 | 554 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 1295 | 0.070 |
Why?
|
| Microcirculation | 1 | 2010 | 1287 | 0.070 |
Why?
|
| Steroids | 1 | 2010 | 930 | 0.060 |
Why?
|
| Genome, Human | 1 | 2018 | 4420 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2022 | 18034 | 0.060 |
Why?
|
| Inflammation | 2 | 2014 | 10637 | 0.060 |
Why?
|
| Electrophysiology | 2 | 2011 | 1308 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 2916 | 0.050 |
Why?
|
| Male | 11 | 2021 | 350115 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2023 | 259 | 0.050 |
Why?
|
| Hot Temperature | 2 | 2021 | 1356 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 21833 | 0.050 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2001 | 39 | 0.050 |
Why?
|
| Biology | 1 | 2023 | 295 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 63107 | 0.050 |
Why?
|
| Sciatic Neuropathy | 1 | 2021 | 74 | 0.050 |
Why?
|
| Antigen-Antibody Complex | 1 | 2022 | 517 | 0.050 |
Why?
|
| Tissue Engineering | 1 | 2011 | 1880 | 0.050 |
Why?
|
| Dipeptides | 1 | 2022 | 409 | 0.050 |
Why?
|
| Median Nerve | 1 | 2020 | 129 | 0.050 |
Why?
|
| Female | 9 | 2021 | 380193 | 0.050 |
Why?
|
| Electrodiagnosis | 1 | 2020 | 151 | 0.050 |
Why?
|
| Physical Stimulation | 1 | 2021 | 525 | 0.040 |
Why?
|
| Biological Assay | 1 | 2022 | 652 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2020 | 440 | 0.040 |
Why?
|
| Nocodazole | 1 | 1998 | 97 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2001 | 437 | 0.040 |
Why?
|
| Stathmin | 1 | 2019 | 71 | 0.040 |
Why?
|
| Somatosensory Cortex | 1 | 2023 | 528 | 0.040 |
Why?
|
| Neurophysiology | 1 | 2019 | 142 | 0.040 |
Why?
|
| Short Interspersed Nucleotide Elements | 1 | 2018 | 40 | 0.040 |
Why?
|
| Potassium Channels | 1 | 2001 | 563 | 0.040 |
Why?
|
| Interneurons | 1 | 2023 | 577 | 0.040 |
Why?
|
| Models, Biological | 1 | 2014 | 9584 | 0.040 |
Why?
|
| Sensory Thresholds | 1 | 2019 | 391 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 23404 | 0.040 |
Why?
|
| Alu Elements | 1 | 2018 | 119 | 0.040 |
Why?
|
| Transcription Factor TFIID | 1 | 2018 | 151 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 12073 | 0.040 |
Why?
|
| Minisatellite Repeats | 1 | 2018 | 165 | 0.040 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2018 | 104 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2001 | 1264 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 5534 | 0.040 |
Why?
|
| Nerve Regeneration | 1 | 2022 | 788 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2018 | 335 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 2019 | 1137 | 0.030 |
Why?
|
| Electromyography | 1 | 2020 | 1379 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2013 | 2949 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 4320 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 992 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 1178 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2019 | 824 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2021 | 3689 | 0.030 |
Why?
|
| Electric Stimulation | 1 | 2019 | 1767 | 0.030 |
Why?
|
| Brain | 2 | 2019 | 26388 | 0.030 |
Why?
|
| Cholestenones | 1 | 2013 | 3 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2023 | 4208 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8038 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2013 | 222 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2013 | 113 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2018 | 748 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2013 | 59 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2001 | 4010 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3554 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2013 | 153 | 0.030 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2014 | 134 | 0.030 |
Why?
|
| Extracellular Space | 1 | 2014 | 595 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Neurites | 1 | 2014 | 388 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 1998 | 1783 | 0.030 |
Why?
|
| Binding Sites | 1 | 2001 | 6111 | 0.030 |
Why?
|
| Cell Line | 2 | 2019 | 16000 | 0.030 |
Why?
|
| Foot Injuries | 1 | 2014 | 148 | 0.030 |
Why?
|
| DNA Replication | 1 | 1998 | 1399 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 323 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 556 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 163288 | 0.020 |
Why?
|
| Haplotypes | 1 | 2018 | 2779 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2001 | 3749 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2019 | 3001 | 0.020 |
Why?
|
| Middle Aged | 3 | 2021 | 213390 | 0.020 |
Why?
|
| Diaphragm | 1 | 2013 | 349 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2013 | 354 | 0.020 |
Why?
|
| Equipment Design | 1 | 2019 | 3582 | 0.020 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2020 | 1433 | 0.020 |
Why?
|
| Presenilin-1 | 1 | 2014 | 635 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2001 | 5451 | 0.020 |
Why?
|
| Benzazepines | 1 | 2013 | 326 | 0.020 |
Why?
|
| Injections | 1 | 2014 | 840 | 0.020 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 172 | 0.020 |
Why?
|
| Neuromuscular Diseases | 1 | 2013 | 247 | 0.020 |
Why?
|
| Cell Cycle | 1 | 1998 | 2967 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2014 | 607 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2014 | 466 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 436 | 0.020 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2013 | 259 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2011 | 982 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 1085 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2013 | 571 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2014 | 1375 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2013 | 721 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2014 | 8300 | 0.020 |
Why?
|
| Tyrosine | 1 | 2013 | 1462 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2018 | 2575 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 1009 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 2010 | 494 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2018 | 3493 | 0.020 |
Why?
|
| Stroke | 1 | 2010 | 9981 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 2726 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1707 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3130 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2015 | 1058 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 2439 | 0.020 |
Why?
|
| Family | 1 | 2018 | 3147 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 1701 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2011 | 711 | 0.020 |
Why?
|
| Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
| Respiration | 1 | 2013 | 1653 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1881 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3595 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 1851 | 0.020 |
Why?
|
| Sindbis Virus | 1 | 2004 | 37 | 0.020 |
Why?
|
| Software | 1 | 2019 | 4441 | 0.020 |
Why?
|
| tau Proteins | 1 | 2014 | 1868 | 0.020 |
Why?
|
| Indoles | 1 | 2013 | 1839 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16690 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2013 | 1480 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 214052 | 0.020 |
Why?
|
| Monocytes | 1 | 2013 | 2596 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1903 | 0.010 |
Why?
|
| Rats | 2 | 2014 | 24252 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8436 | 0.010 |
Why?
|
| Cell Survival | 1 | 2013 | 5882 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2011 | 1423 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2018 | 13035 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 1620 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2004 | 363 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 12802 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 937 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3084 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 1 | 2014 | 3587 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2013 | 2962 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 1202 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 2475 | 0.010 |
Why?
|
| Neutrophils | 1 | 2013 | 3721 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2004 | 957 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2004 | 1730 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7914 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 7023 | 0.010 |
Why?
|
| Diploidy | 1 | 1998 | 138 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 1988 | 0.010 |
Why?
|
| G1 Phase | 1 | 1998 | 415 | 0.010 |
Why?
|
| Cyclins | 1 | 1998 | 603 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
| Genes, p53 | 1 | 1998 | 755 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 3773 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 1723 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1998 | 530 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9445 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2018 | 40559 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1998 | 705 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 1998 | 1793 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13814 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 9384 | 0.010 |
Why?
|
| Temperature | 1 | 1998 | 2204 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 18111 | 0.010 |
Why?
|